Brian Chapin
M.D. Anderson Cancer Center · SWOG Cancer Research Network
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Brian Chapin as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:39 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT06066437 · NeoAdjuvant Theranostic Lutetium Study: The Nautilus TrialM.D. Anderson Cancer Center · recruiting · Prostate Cancer · principal investigator
- Ph3NCT03678025 · Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate CancerSWOG Cancer Research Network · recruiting · Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:39 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- SWOG Network Group Operations Center of the NCTNU10CA180888 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI DAWN HERSHMAN, PRIMO N. LARA · fiscal years 2014 to 2026Named on NCT03678025
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 09:39 UTC. The ranking covers the 200 most relevant of 10 PubMed records, and a shared surname and initials can bring in a namesake. All 10 on PubMed
- 195 citationsRCR 16.1
- Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancer.Sci Transl Med · 2020134 citationsRCR 4.5
- Neuropsychiatric profiles in dementia.Alzheimer Dis Assoc Disord · 201160 citationsRCR 2.3
- 29 citationsRCR 5.3
- Abiraterone acetate plus prednisone in non-metastatic biochemically recurrent castration-naïve prostate cancer.Eur J Cancer · 202119 citationsRCR 0.9
- 7 citationsRCR 1.1
- 7 citationsRCR 1.0
- A phase II trial of apalutamide for intermediate-risk prostate cancer and molecular correlates.BJU Int · 20244 citationsRCR 0.7
- Randomized Phase 2 Trial of Presurgical Androgen Deprivation Therapy With or Without Axitinib in Prostate Cancer Presenting With Lymph Node Metastasis.Eur Urol Oncol · 20252 citationsRCR 0.3